Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infantile Fibrosarcoma With NTRK3–ETV6 Fusion Successfully Treated With the Tropomyosin‐Related Kinase Inhibitor LOXO‐101

Published:2016-04-19 Issue:8 Volume:63 Page:1468-1470
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Nagasubramanian Ramamoorthy¹,Wei Julie¹,Gordon Paul¹,Rastatter Jeff C.²,Cox Michael C.³,Pappo Alberto⁴

Affiliation:

1. Nemours Children's Hospital Orlando Florida

2. Department of Otolaryngology – Head and Neck Surgery Northwestern University Feinberg School of Medicine Chicago Illinois

3. Loxo Oncology Inc South San Francisco California

4. St. Jude Children's Research Hospital Memphis Tennessee

Funder

Loxo Oncology, Inc.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.26026

Reference21 articles.

1. Infantile fibrosarcoma

2. Treatment of Infantile Fibrosarcoma With Chemotherapy and Surgery: Results From the Dana-Farber Cancer Institute and Children's Hospital, Boston

3. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience

4. Infantile Fibrosarcoma: Management Based on the European Experience

5. ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib;Cell Death & Disease;2024-05-30

2. Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing;Translational Pediatrics;2024-04

3. Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022;Results in Chemistry;2024-01

4. Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements;Frontiers in Cell and Developmental Biology;2023-10-18

5. Marginal resection as a potential curative treatment option of infantile fibrosarcoma with good response after chemotherapy: A case report of an ETV6-NTRK3 positive infantile fibrosacroma of the distal tibia;Medicine;2023-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3